SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Graybug Vision, Inc. – ‘S-8 POS’ on 3/18/22

On:  Friday, 3/18/22, at 4:00pm ET   ·   Effective:  3/18/22   ·   Accession #:  1564590-22-11051   ·   File #:  333-263464

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/22  Graybug Vision, Inc.              S-8 POS     3/18/22    2:74K                                    ActiveDisclosure/FA

Post-Effective Amendment of a Form S-8 Registration

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8 POS     Post-Effective Amendment of a Form S-8              HTML     25K 
                Registration                                                     
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     15K 


‘S-8 POS’   —   Post-Effective Amendment of a Form S-8 Registration


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

As filed with the Securities and Exchange Commission on March 18, 2022

Registration No. 333-263464

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

POST EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

GRAYBUG VISION, INC.

(Exact name of registrant as specified in its charter)

Delaware

452120079

(State or other jurisdiction of

Incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

203 Redwood Shores Parkway, Suite 620

Redwood City, CA

94065

(Address of Principal Executive Offices)

(Zip Code)

 

2020 Equity Incentive Plan

(Full title of the plan)

Frederic Guerard

Chief Executive Officer

Graybug Vision, Inc.

203 Redwood Shores Parkway, Suite 620

Redwood City, CA 94065

(650) 487-2800

 

(Name, address, and telephone number, including area code, of agent for service)

Please send copies of all communications to:

 

Effie Toshav, Esq.

Robert A. Freedman, Esq.

Julia Forbess, Esq.
Fenwick & West LLP
555 California Street, 12th Floor

San Francisco, California 94104
(415) 875-2300


 


 

 

Explanatory Note

This Post-Effective Amendment No. 1 to Registration Statement on Form S-8 (this “Registration Statement”) is being filed solely to correct a clerical error that resulted in a missing signature on Exhibit 5.1, opinion of Fenwick & West LLP, included as an exhibit to the Registration Statement on Form S-8 (File No. 333-263464) filed with the Securities and Exchange Commission on March 11, 2022 (the “Original Filing”). An updated Exhibit 5.1 with the updated signature is being filed as an exhibit to this Registration Statement.

 

Except as described above, this Registration Statement does not update, amend or modify any other information, statement or disclosure contained in the Original Filing.

 

Item 8. Exhibits

 

The exhibit to be filed or included as part of this Post-Effective Amendment No. 1 is as follows:

5.1*

Opinion of Fenwick & West LLP.

23.1

Consent of Fenwick & West LLP (contained in Exhibit 5.1)

*Filed herewith


 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Redwood City, State of California, on this 18th day of March, 2022.

GRAYBUG VISION, INC.

 

 

By:

/s/ Frederic Guerard, Pharm.D.

 

 

Frederic Guerard, Pharm.D.

 

 

Chief Executive Officer and President

 

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

Name

 

Title

 

Date

 

 

 

 

 

/s/ Frederic Guerard

 

Chief Executive Officer and Director

 

March 18, 2022

Frederic Guerard, Pharm.D.

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Robert S. Breuil

 

Chief Financial Officer

 

March 18, 2022

Robert S. Breuil

 

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

Christy Shaffer*

 

Chairperson, Director

 

March 18, 2022

Christy Shaffer, Ph.D.

 

 

 

 

 

 

 

 

 

Christina Ackermann*

 

Director

 

March 18, 2022

Christina Ackermann

 

 

 

 

 

 

 

 

 

 

 

Director

 

March 18, 2022

Eric Bjerkholt

 

 

 

 

 

 

 

 

 

Gerald Cagle, Ph.D.*

 

Director

 

March 18, 2022

Gerald Cagle, Ph.D.

 

 

 

 

 

 

 

 

 

Julia Eastland*

 

Director

 

March 18, 2022

Julie Eastland

 

 

 

 

 

 

 

 

 

 

By:*/s/ Robert S. Breuil.

Robert S. Breuil, as attorney-in-fact

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8 POS’ Filing    Date    Other Filings
Filed on / Effective on:3/18/22
3/11/2210-K,  S-8
 List all Filings 
Top
Filing Submission 0001564590-22-011051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 5:18:54.0pm ET